Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta

  1. Eric Engelbrecht
  2. Michel V Levesque
  3. Liqun He
  4. Michael Vanlandewijck
  5. Anja Nitzsche
  6. Hira Niazi
  7. Andrew Kuo
  8. Sasha A Singh
  9. Masanori Aikawa
  10. Kristina Holton
  11. Richard L Proia
  12. Mari Kono
  13. William T Pu
  14. Eric Camerer
  15. Christer Betsholtz
  16. Timothy Hla  Is a corresponding author
  1. Harvard Medical School, United States
  2. Uppsala University, Sweden
  3. Université de Paris, INSERM U970, Paris Cardiovascular Research Center, France
  4. Brigham and Women's Hospital, Harvard Medical School, United States
  5. Harvard Medical School Research Computing, United States
  6. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, United States
  7. Boston Children's Hospital, Harvard Medical School, United States

Abstract

Despite the medical importance of G protein-coupled receptors (GPCRs), in vivo cellular heterogeneity of GPCR signaling and downstream transcriptional responses are not understood. We report the comprehensive characterization of transcriptomes (bulk and single-cell) and chromatin domains regulated by sphingosine 1-phosphate receptor-1 (S1PR1) in adult mouse aortic endothelial cells. First, S1PR1 regulates NFkB and nuclear glucocorticoid receptor pathways to suppress inflammation-related mRNAs. Second, S1PR1 signaling in the heterogenous endothelial cell (EC) subtypes occurs at spatially-distinct areas of the aorta. For example, a transcriptomically distinct arterial EC population at vascular branch points (aEC1) exhibits ligand-independent S1PR1/β-arrestin coupling. In contrast, circulatory S1P-dependent S1PR1/β-arrestin coupling was observed in non-branch point aEC2 cells that exhibit an inflammatory gene expression signature. Moreover, S1P/S1PR1 signaling regulates the expression of lymphangiogenic and inflammation-related transcripts in an adventitial lymphatic EC (LEC) population in a ligand-dependent manner. These insights add resolution to existing concepts of GPCR signaling and S1P biology.

Data availability

Sequencing data and processed files have been deposited in GEO under the accession GSE139065.

The following data sets were generated

Article and author information

Author details

  1. Eric Engelbrecht

    Vascular Biology Program, Boston Children's Hospital and Department of Surgery Deapartment of Surgery, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  2. Michel V Levesque

    Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  3. Liqun He

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
  4. Michael Vanlandewijck

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
  5. Anja Nitzsche

    Université de Paris, INSERM U970, Paris Cardiovascular Research Center, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0567-6790
  6. Hira Niazi

    Université de Paris, INSERM U970, Paris Cardiovascular Research Center, Paris, France
    Competing interests
    No competing interests declared.
  7. Andrew Kuo

    Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  8. Sasha A Singh

    Center for Interdisciplinary Cardiovascular Sciences, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  9. Masanori Aikawa

    Center for Interdisciplinary Cardiovascular Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9275-2079
  10. Kristina Holton

    Harvard Medical School Research Computing, Boston, United States
    Competing interests
    No competing interests declared.
  11. Richard L Proia

    Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0456-1270
  12. Mari Kono

    Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2447-4350
  13. William T Pu

    Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4551-8079
  14. Eric Camerer

    Université de Paris, INSERM U970, Paris Cardiovascular Research Center, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6271-7125
  15. Christer Betsholtz

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
  16. Timothy Hla

    Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School, Boston, United States
    For correspondence
    timothy.hla@childrens.harvard.edu
    Competing interests
    Timothy Hla, received grant support from ONO Pharmaceuticals (2015-2018), has filed patent applications on ApoM, ApoM-Fc and HDL containing ApoM (US 62/545,629, PCT/US2018/000202, US 62/744,903, PCT/US2019/055831, US16/326,089, CA3034243, CN201780056922.6, JP 2019-530362, EPO 17851271.1), and has consulted for the following commercial entities: Astellas, Steptoe and Johnson, Gerson Lehrman Group Council, Janssen Research & Development, LLC, and Sun Pharma advanced research group (SPARC).
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8355-4065

Funding

National Heart, Lung, and Blood Institute (R35 HL135821)

  • Timothy Hla

Fondation Leducq (SphingoNet Transatlantic Network Grant)

  • Richard L Proia
  • Eric Camerer
  • Christer Betsholtz
  • Timothy Hla

National Institute of Diabetes and Digestive and Kidney Diseases (Intramural program support)

  • Richard L Proia

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Victoria L Bautch, University of North Carolina, Chapel Hill, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#16-10-3297) of the Boston Children's Hospital. All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.

Version history

  1. Received: October 12, 2019
  2. Accepted: February 22, 2020
  3. Accepted Manuscript published: February 24, 2020 (version 1)
  4. Version of Record published: March 3, 2020 (version 2)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 4,032
    Page views
  • 475
    Downloads
  • 28
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Eric Engelbrecht
  2. Michel V Levesque
  3. Liqun He
  4. Michael Vanlandewijck
  5. Anja Nitzsche
  6. Hira Niazi
  7. Andrew Kuo
  8. Sasha A Singh
  9. Masanori Aikawa
  10. Kristina Holton
  11. Richard L Proia
  12. Mari Kono
  13. William T Pu
  14. Eric Camerer
  15. Christer Betsholtz
  16. Timothy Hla
(2020)
Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta
eLife 9:e52690.
https://doi.org/10.7554/eLife.52690

Share this article

https://doi.org/10.7554/eLife.52690

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Erandi Velazquez-Miranda, Ming He
    Insight

    Endothelial cell subpopulations are characterized by unique gene expression profiles, epigenetic landscapes and functional properties.

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Monica Salinas-Pena, Elena Rebollo, Albert Jordan
    Research Article

    Histone H1 participates in chromatin condensation and regulates nuclear processes. Human somatic cells may contain up to seven histone H1 variants, although their functional heterogeneity is not fully understood. Here, we have profiled the differential nuclear distribution of the somatic H1 repertoire in human cells through imaging techniques including super-resolution microscopy. H1 variants exhibit characteristic distribution patterns in both interphase and mitosis. H1.2, H1.3, and H1.5 are universally enriched at the nuclear periphery in all cell lines analyzed and co-localize with compacted DNA. H1.0 shows a less pronounced peripheral localization, with apparent variability among different cell lines. On the other hand, H1.4 and H1X are distributed throughout the nucleus, being H1X universally enriched in high-GC regions and abundant in the nucleoli. Interestingly, H1.4 and H1.0 show a more peripheral distribution in cell lines lacking H1.3 and H1.5. The differential distribution patterns of H1 suggest specific functionalities in organizing lamina-associated domains or nucleolar activity, which is further supported by a distinct response of H1X or phosphorylated H1.4 to the inhibition of ribosomal DNA transcription. Moreover, H1 variants depletion affects chromatin structure in a variant-specific manner. Concretely, H1.2 knock-down, either alone or combined, triggers a global chromatin decompaction. Overall, imaging has allowed us to distinguish H1 variants distribution beyond the segregation in two groups denoted by previous ChIP-Seq determinations. Our results support H1 variants heterogeneity and suggest that variant-specific functionality can be shared between different cell types.